Menu

Gel Heals Heart Attack Injury

A collagen patch seeded with a regenerative protein helps mice and pigs regain cardiac function after a heart attack.

Sep 18, 2015
Kerry Grens

New heart muscle cells (green with yellow nuclei) grow in the infarcted region of a mouse heart treated by the patch loaded with FSTL1.UC SAN DIEGO/SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTETo find a way to repair the damage that happens to cardiac tissue after a heart attack, researchers have developed a patch that delivers a regenerative molecule to the organ’s surface. A team led by Stanford University’s Pilar Ruiz-Lozano reported in Nature yesterday (September 16) that the implant helps restore cardiac function to mice and pigs who have had a heart attack.

“Many were so sick prior to getting the patch that they would have been candidates for heart transplantation,” Ruiz-Lozano told BBC News. “The hope is that a similar procedure could eventually be used in human heart attack patients who suffer severe heart damage.”

The scientists conducted a screen for molecules that could spur the production of cardiomyocytes in vitro, and homed in on a protein, Follistatin-like 1 (FSTL1). They then designed a collagen-based material coated in FSTL1, and placed it on the hearts of pigs and mice forced to have a heart attack.

Within a month, the researchers observed cardiomyocyte division among animals treated with FSTL1, along with improved cardiac function, less scarring, and better survival.

“It could act like a cell nursery,” Ruiz-Lozano said in a press release. “It’s a hospitable environment. Over time, it gets remodeled and becomes vascularized as new muscle cells come in.”

“This study is an inspiring example of how a developmentally conserved regulatory pathway can be mobilized to induce heart regeneration,” Gordana Vunjak-Novakovic of Columbia University wrote in an accompanying commentary. “Although more work needs to be done to determine the benefits of such an approach in large-animal models (the authors conducted a preliminary study in pigs, but it involved only six animals divided into three groups), the proposed reconstitution of epicar­dial Fstl1 could lead to entirely new modalities for treating heart infarction.”

Ruiz-Lozano has a startup company working to develop the patch for clinical trials in humans.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening